Introduction
============

The extensive use of indwelling devices such as prosthetic joints, heart valves, and intravascular catheters in hospitalized patients has increased the incidence of device related infections (DRI) ([@B20]). DRI constitute a growing healthcare concern because they are associated with a high morbidity and mortality and also with increased costs in health care systems. *Staphylococcus aureus* is a frequent etiological agent of DRI, especially those related with intravascular catheters, prosthetic joints, vascular grafts and pacemakers ([@B22]; [@B26]; [@B12]).

The success of *S. aureus* as a pathogen depends on the combined action of multiple factors. On one hand, *S. aureus* produces a wide array of cell surface and secreted virulence factors such as exoenzymes (coagulase, lipases, and proteases), toxins (cytolytic toxins, enterotoxins, exfoliative toxins) and immune evasion mechanisms (protein A) ([@B14]). Cell surface virulence factors allow the organism to colonize the host through adhesion to mucosal surfaces and to interfere with normal immune system functions. Secreted factors, including exoenzymes and exotoxins, allow the organism to spread into surrounding tissues and access nutrients through cell damage. On the other hand, *S. aureus* exhibits a great capacity to adapt to many different environments including almost every organ of the human body (lung, heart, blood, bone, skin, muscles, eye, joints, and intestinal tract). For that, *S. aureus* possesses efficient signal transduction systems that facilitate the integration of environmental stimuli and adjust the cellular physiology in response ([@B31]; [@B7]; [@B19]). The sensory machinery of *S. aureus* is composed of the two-component systems (TCS) network, a Ser/Thr protein kinase, two Ser/Thr phosphatases and a c-di-AMP cyclase (Dac) and a phosphodiesterase (GpdP) involved in c-di-AMP metabolism. As regards the TCS network, most *S. aureus* strains contain 16 TCSs, with one of them being essential for bacterial viability ([@B23]). In a canonical TCS, extracellular stimuli induce the autophosphorylation of a histidine kinase (HK). The activated HK transfers the phosphoryl group to a conserved aspartate residue present on the response regulator (RR). The phosphorylation of the RR activates an output domain, which can then effect changes in cellular physiology often by regulating gene expression ([@B42]).

When *S. aureus* reaches the surface of an implanted medical device, attachment to the surface occurs through interactions between bacterial adhesins and plasma proteins deposited on the implant's surface. Once attached, *S. aureus* needs to adjust bacterial physiology to the sessile lifestyle. For that, *S. aureus* produces an extracellular matrix mainly composed of exopolysaccharides, proteins and extracellular DNA ([@B32]; [@B37]). The exopolysaccharide PNAG, also named PIA (polysaccharide intercellular adhesin) is a major component of the staphylococcal biofilm matrix. PNAG, β-1,6-linked *N*-acetylglucosamine, is synthetized by the enzymes encoded in the *icaADBC* operon whose expression is tightly regulated by the transcriptional repressor IcaR. Some strains of *S. aureus* make use of extracellular proteins to build the biofilm matrix by interacting with eDNA and polysaccharides or in some cases, through polysaccharide-independent mechanisms ([@B11]; [@B9]; [@B33]; [@B50]; [@B43]). Although the molecular determinants underlying the choice of either a polysaccharide or protein-based biofilm matrix are not well understood, it is assumed that environmental signals determine the composition of the biofilm matrix ([@B50]). Attempts to identify the specific TCSs involved in the biofilm formation process of *S. aureus in vitro* have been previously performed ([@B45]). However, identification of TCSs important for colonization of implanted medical devices *in vivo* remains to be elucidated.

In this study, we used a collection of single mutants in each non-essential TCS of *S. aureus* and a murine subcutaneous catheter infection model to identify the TCSs controlling the production and composition of the biofilm matrix on the surface of the implanted device. Our results revealed that *arlRS*, and in a lower extent *agr* and *srrAB* mutants, have a significant decreased capacity in colonize the surface of implanted catheters. In the *arl* mutant background, expression of the *icaADBC* operon restores the capacity to colonize the catheter, indicating that the PNAG exopolysaccharide is required for efficient colonization of implanted catheters. This result is central to the development of novel therapeutic approaches to specifically target biofilm related infections.

Materials and Methods {#s1}
=====================

Oligonucleotides, Plasmids, Bacterial Strains, and Culture Conditions
---------------------------------------------------------------------

Bacterial strains, plasmids and oligonucleotides (Stabvida) used in this study are listed in Supplementary Tables [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM2){ref-type="supplementary-material"}. *Escherichia coli* strains were grown in LB broth (Conda-Pronadisa). *S. aureus* strains were grown in trypticase soy broth (TSB) (Conda-Pronadisa), TSB supplemented with glucose (TSBg) in strain ISP479r or NaCl 3% (TSB-NaCl) in the case of strain 132. When required for selection, medium was supplemented with appropriate antibiotics at the following concentrations: erythromycin (Em), 1.5 and 10 μg ml^-1^; ampicillin (Amp), 100 μg ml^-1^.

DNA Manipulations and Bacterial Transformation
----------------------------------------------

General DNA manipulations were performed using standard procedures. Plasmids were purified using the NucleoSpin Plasmid miniprep kit (Macherey-Nagel) according to the manufacturer's protocol. FastDigest restriction enzymes and Rapid DNA ligation kit (Thermo Scientific) were used according to the manufacturer's instructions. Plasmids were transformed into *E. coli XL1-Blue* strain (Stratagene) and *S. aureus* by electroporation, using previously described protocols ([@B11]). Staphylococcal electrocompetent cells were generated as previously described ([@B39]).

Allelic Exchange of Chromosomal Genes
-------------------------------------

We used a collection of single mutants in each TCS constructed in *S. aureus* MW2 (listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) by [@B51] as follows. Fragments of at least 500 bp that flanked the left (primers A and B) and right sequences (primers C and D) of the region targeted for deletion were amplified by PCR. The PCR products AB and CD were used to obtain an overlapping PCR product named AD, which was cloned into the shuttle vector pMAD ([@B2]) or pMAD_lic. A LIC-modified pMAD vector was constructed in order to enable efficient directional cloning without restriction enzyme digestion or ligation reactions ([@B1]). To create the pMAD_lic vector we oligomerized the primers pMAD_lic (EcoRI) and pMAD_lic (BamHI) listed in Supplementary Table [S2](#SM2){ref-type="supplementary-material"}, and cloned the double DNA strand dimer into pMAD using EcoRI and BamHI restriction enzymes. To produce specific non-complementary overhangs in the pMAD_lic vector, the ApaI linearized plasmid was treated with T4 DNA Polymerase (Novagen) in the presence of dTTP (Novagen) for 30 min at 22°C. PCR products with complementary overhangs were created using Phusion enzyme (Thermo Scientific) by building appropriate 5′ extensions into the primers. The PCR products were purified and then treated with T4 DNA Polymerase in the presence of dATP (Novagen) at 22°C. After 30 min the enzyme was inactivated. To anneal the insert into the pMAD_lic vector, the mix of vector and insert was incubated for 5 min at 22°C and then, EDTA (6.25 mM) was added and a further incubation of 5 min at 22°C was applied. To express the *ica* operon and *mgrA* gene under de cadmium promoter, we amplified the cadmium inducible promoter from pCN51 plasmid (*P*~cd~) ([@B5]) and two fragments of at least 500 bp that flanked the left (primers A and B) and right sequences (primers C and D) of the start of the mRNA of both genes. Three fragments were fused by overlapped PCR. The purified fragment was cloned into the pMAD_lic plasmid. Allelic exchange in the absence of a selection marker was performed as previously described ([@B48]). White colonies, which no longer contained the pMAD plasmid, were tested to confirm the replacement by PCR using primers E and F (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). Note that cadmium was not used for the expression of *P*~cd~ since the leakage of expression of the *P*~cd~ promoter was sufficient to express PNAG and MgrA.

PNAG Detection
--------------

Overnight cultures of the strains tested were diluted 1:40 in the appropriate medium, and 2 ml of this cell suspension was used to inoculate sterile 24-well polystyrene microtiter plates (Sarstedt). After 16 h cell-surface PNAG production was detected as described previously ([@B48]). 5 μl of the extract or 5 μl of a dilution of the purified extract were spotted on a nitrocellulose filter using a Bio-Dot microfiltration apparatus (Bio-Rad), blocked overnight with 5% skim milk in phosphate-buffered saline with 0.1% Tween 20, and incubated for 2 h with an anti-PNAG antibody diluted 1:10,000 ([@B28]). Bound antibodies were detected with peroxidase-conjugated goat anti-rabbit immunoglobulin G anti-bodies (Invitrogen) 1:5,000.

Generation of *ica* and *mgrA* Transcriptional Fusions With Gfp
---------------------------------------------------------------

To obtain an *ica* and *mgrA* transcriptional fusions, we amplified the *ica* promoter using primers AU59 and AU76 and the *mgrA* promoter using primers PmgrA-fw and Pmgra-rv (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}) and cloned in pCN52 plasmid ([@B5]), giving pCN52-P~*ica*(*BS*)-~gfp and pCN52-P~mgrA~-gfp plasmids, respectively. Plasmids were transformed in *S. aureus* wild type strains and *arl* mutants. To analyze *ica* and *mgrA* expression, total protein extracts were recovered and analyzed by SDS-PAGE and Western blot Gfp was detected using anti-GFP \[Living Color^®^ A.v. Monoclonal Antibody (JL-8), Clontech\] antibodies diluted 1:2,500 in 0.1% PBS-Tween 5% skim-milk. Peroxidase-conjugated goat anti-mouse Immunoglobulin G (Invitrogen) diluted 1:5000 in 0.1% PBS-Tween 5% skim-milk were used as secondary antibodies.

RNA Extraction and Northern-Blot
--------------------------------

*Staphylococcus aureus* 132 and *arl* strains were grown in 10 ml of TSB-NaCl at 37°C under static conditions for 5 h. RNA extraction was performed as described previously ([@B24]). Northern blots were performed as described ([@B38]). Briefly, 8 μg of total RNA was separated in precast agarose gels (Sigma). RNAs were blotted onto Nytran membranes (0.2-μm pore size) (Amersham Biosciences), UV cross-linked, prehybridized in ULTRAhyb solution (Ambion) at 65°C, and labeled with strand-specific riboprobes specific for *icaA, icaC*, and *icaR* (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). Membranes were washed and autoradiography images were registered at different exposition times according to each gene.

Protein Tagging and Immunodetection Analysis
--------------------------------------------

Transfer of the 3xFlag sequence into IcaC was achieved by recombination using plasmid pMADicaC-3xFlag. To construct pMADicaC-3xFlag the C-terminal region of *icaC* was amplified using primers CFlag1 and CFlag2 (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). The CFlag2 primer contains 66 nt that code for the 3xFlag sequence. Strains containing IcaC-3xFlag were grown in TSB-NaCl or TSBg at 37°C under static conditions for 5 h. Then, cells were centrifuged and the pellets were resuspended in PBS buffer containing lysostaphin (12.5 μg/ml; Sigma) and DNase I for 2 h. Samples were subjected to electrophoresis on SDS-PAGE 12% Criterion^TM^ TGX Stain-Free^TM^ Precast Gels (Bio-Rad). Proteins were transferred onto nitrocellulose membranes (Hybond Amersham Biosciences) and 3xFLAG fusion proteins were immunodetected by the use of anti-FLAG M2 mAbs conjugated with peroxidase (Sigma).

Affinity Blotting of Ebh
------------------------

For detection of the levels of Ebh protein overnight cultures of the different strains were diluted 1:100 in 50 ml of TSB-glu medium and grown at 37°C to a mid-log exponential phase (OD = 0.8). Surface-associated proteins were extracted as previously described ([@B43]). Proteins were subjected to electrophoresis on SDS-PAGE 7.5% TGX Stain-Free^TM^ FastCast^TM^ Acrylamide Kit (Bio-Rad). For immunoblotting, proteins were transferred onto Hybond-ECL nitrocellulose membranes (Amersham Biosciences). Membranes were blocked for 2 h at room temperature with 5% skimmed milk in PBS with 0.1% Tween 20 and incubated overnight at 4°C with specific antibodies for the carboxy-terminal region of Ebh diluted 1:1,000. Bound antibodies were detected with peroxidase-conjugated goat anti-rabbit immunoglobulin G anti-bodies (Invitrogen) 1:5,000.

Murine Model of Catheter-Associated Biofilm Formation
-----------------------------------------------------

To examine the role of the staphylococcal TCSs in implant colonization, an *in vivo* murine model of catheter-associated biofilm formation described by [@B11] was used with some modifications. *S. aureus* strains grown overnight at 37°C on TSA plates were resuspended in PBS to an optical density of OD~650\ nm~ = 0.2 (10^8^ CFU/mL). Groups of 5, 5 weeks old ICR female mice (Charles River Laboratories) were anesthetized with isoflurane (B. Braun). Two 19 mm intravenous catheters (24G; B. Braun) were aseptically implanted into the subcutaneous interscapular of each mouse and inoculated with 100 μl (10^7^ CFU) of *S. aureus* strains. After 5 days, animals were opportunely euthanatized by isoflurane inhalation followed by cervical dislocation. Catheters were aseptically removed, placed in a sterile microcentrifuge tube containing 1 ml of PBS, and vortexed at high speed for 3 min. The number of bacteria was determined by plate count.

Ethics Statement
----------------

All animal studies were reviewed and approved by the Comité de Ética para la Experimentación Animal (CEEA) of the Universidad de Navarra (approved protocol 032-17). Work was carried out at the Centro de Investigación Médica Aplicada building (ES312010000132) under the principles and guidelines described in European Directive 2010/63/EU for the protection of animals used for experimental purposes.

Statistical Analysis
--------------------

Statistical analyses were performed with the GraphPad Prism 5.01 program. The multiple comparison Tukey's test was used in mice infection assays to find means that are significantly different from each other.

Results
=======

Involvement of the *S. aureus* TCS Signaling System in the Colonization of Subcutaneous Catheters
-------------------------------------------------------------------------------------------------

Since the TCS network is essential for *S. aureus* to adapt to new environments, we hypothesized that one or several TCSs might be involved in environmental sensing and activation of genes that code for biofilm-related factors needed for implant colonization. To address this question, we proceeded to systematically analyze the involvement of each TCS in the colonization of subcutaneous foreign catheters ([@B11]; [@B50]) (**Figure [1](#F1){ref-type="fig"}**) by comparing the levels of catheter-associated biofilm formation of the methicillin-resistant *S. aureus* wild type MW2 strain to those of a collection of single MW2 mutants in each TCS ([@B51]). Because differences in growth rates could affect the capacity to colonize the catheters, we first analyzed the growth rate of each mutant under the laboratory growth conditions. The results revealed no significant differences in growth rates between the collection of mutants deficient in TCS and the wild type strain (Supplementary Figure [S1](#SM3){ref-type="supplementary-material"}). Results showed that 3 TCS single mutants, namely *arl*, *srr*, and *agr*, showed significantly decreased colonization (**Figure [2](#F2){ref-type="fig"}**). Interestingly, the *arl* mutant showed the greatest deficit in colonization of implanted catheters amongst all single TCS mutants. These results indicated that ArlRS, SrrAB, and Agr TCSs are concomitantly needed for biofilm formation in this DRI model, with ArlRS playing a major role in the process.

![Schematic illustrating the murine model of catheter-associated biofilm formation. **(A)** ICR female mice were anesthetized by isoflurane and the skin was cleansed with alcohol prior to surgery. The bottom of 19 mm catheters (Introcan Safety 24G; B. Braun) was cut right before insertion (dotted line). **(B)** Then, two catheters were inserted into the subcutaneous interscapular space of each mice and 100 μl of the bacterial suspension containing 10^7^ CFU of the strain under study were injected through the Introcan Devices into the catheters. In all the experiments, five mice were used for each strain under study, so that a total of ten catheters were inoculated with each strain. **(C)** Introcan Devices were carefully pulled out from mice and wounds were closured with the tissue adhesive Histoacryl^®^ (B. Braun) so that catheters remained inside for 5 days. Note that although closuring the wounds, some catheters were naturally pulled out from mice during the course of experiments. **(D)** Mice were euthanized, catheters were aseptically removed, placed in a sterile microcentrifuge tube containing 1 ml of PBS and vigorously vortexed for 3 min to remove adherent bacteria. **(E)** Bacteria were enumerated by viable plate counts.](fmicb-09-00342-g001){#F1}

![Systematic analysis of the contribution of the TCS signaling system to catheter colonization. Comparison of catheter colonization capacity of the wild type strain (MW2) and single mutants in each non-essential TCS. Bacteria were not detectable in control catheters that had been inoculated with PBS (detection limit 100 CFU/catheter). Note that although a total of ten catheters were inoculated with each strain, a variable number of catheters were recovered in each group due to natural catheter expulsion from mice during the course of the experiment. The plots display values obtained from individual catheters and the mean is represented by horizontal bars. Statistical significance was determined with one-way ANOVA followed by Tukey's multiple comparison test comparing to the WT strain. ^∗^*P* \< 0.05, ^∗∗∗^*P* \< 0.001.](fmicb-09-00342-g002){#F2}

Synthesis of the PNAG Exopolysaccharide Is Abolished in an *arl* Mutant Strain
------------------------------------------------------------------------------

Since the exopolysaccharide PNAG is one of the main components of the *S. aureus* biofilm matrix, we next investigated whether the deficit in catheter colonization shown by the *arl* mutant strain correlated with an altered capacity to produce PNAG. To do so, we determined PNAG production in *arl* by dot-blot, using antibodies anti-PNAG, and compared it to that of the wild type strain and the rest of single MW2 mutants in each TCS. Interestingly, the *arl* mutant strain showed a null capacity to produce PNAG. In contrast, the rest of the mutants displayed a similar, slightly higher or slightly lower PNAG production capacity than the wild type strain (**Figure [3A](#F3){ref-type="fig"}**). To extend the observed PNAG deficient phenotype of the *arl* mutant to other strain backgrounds, we deleted the *arlRS* genes in the genetically unrelated *S. aureus* strains 132 (methicillin-resistant) and ISP479r (methicillin-susceptible). Deficiency in PNAG production was confirmed in both *arl* mutant strains (**Figure [3B](#F3){ref-type="fig"}**). Moreover, complementation of the *S. aureus* MW2 *arl* mutant with the pCN51 plasmid expressing the *arl* sensor and response regulator genes under the expression of the PCad promoter (p*arlRS*) led to complete restoration of the capacity to produce PNAG (**Figure [3C](#F3){ref-type="fig"}**). Such restoration was completely dependent on the presence of *icaADBC* genes, since complementation of the *arl* mutant with p*arlRS* in a Δ*icaADBC* background did not result in PNAG production (**Figure [3C](#F3){ref-type="fig"}**). Altogether, these results showed that the ArlRS TCS is required for PNAG production in *S. aureus* and suggested a link between the incapacity of *arl* to synthesize PNAG and the deficiency shown by this mutant in the *in vivo* model of subcutaneous catheter colonization.

![*Staphylococcus aureus arlRS* mutants do not synthesize PNAG. **(A)** Dot blot analysis of the PNAG exopolysaccharide synthesized by the wild type MW2 strain and the collection of single mutants in each non-essential TCS. **(B)** Dot blot analysis of PNAG synthesized by the wild type 132 and ISP479r strains and their corresponding *arl* mutants. **(C)** Dot blot analysis of PNAG produced by *S. aureus* MW2, a single *arl* and double *arl*-Δ*ica* mutant strains complemented with plasmid p*arlRS*, which overexpresses the *arlRS* genes under the expression of their own promoter. In all cases, samples were analyzed after 16 h of static incubation, at 37°C, in TSB (MW2 and derivatives), TSB NaCl (132) and TSBg (ISP479r). Serial dilutions (1/10) of the samples were spotted onto nitrocellulose membranes and PNAG production was detected with specific anti PIA/PNAG antibodies. UD; undiluted sample. Numbers below the image show relative dot quantification according to densitometry analysis performed with ImageJ (<http://rsbweb.nih.gov/ij/>).](fmicb-09-00342-g003){#F3}

Activation of PNAG Production by ArlRS Is Required for *in Vivo* Catheter Associated Biofilm Formation
------------------------------------------------------------------------------------------------------

To investigate the possibility that catheter colonization deficiency of the *arl* mutant strain might be due to its failure to produce PNAG, we firstly analyzed catheter colonization capacity of an *arl* mutant in which the *icaADBC* operon was expressed from the chromosome, under the Pcd promoter (*arl*-P~cd~\_ica strain). Restoration of PNAG production in this strain (**Figure [4A](#F4){ref-type="fig"}**) resulted in colonization levels similar to the wild type strain (**Figure [4B](#F4){ref-type="fig"}**), indicating that the absence of PNAG in *arl* strain is in fact the reason for its defect in biofilm formation on subcutaneous catheters. Accordingly, a MW2 Δ*icaADBC* mutant, incapable of synthesizing PNAG (**Figure [4A](#F4){ref-type="fig"}**), showed a significantly reduced capacity to colonize catheters compared with the wild type strain (**Figure [4B](#F4){ref-type="fig"}**). Additionally, we investigated catheter colonization of *S. aureus* MW2 derivative mutants in surface proteins whose expression is known to be regulated by ArlRS and that are involved in multicellular behavior ([@B30]; [@B8]; [@B10]). Results showed that neither protein played a role in biofilm formation on subcutaneous catheters (Supplementary Figure [S2](#SM4){ref-type="supplementary-material"}). Overall, these findings indicated that the ArlRS TCS governs the process of *S. aureus* catheter colonization through activation of the synthesis of the PNAG exopolysaccharide, which is fundamental to the formation of a biofilm on the surface of the subcutaneous implanted device.

![Overexpression of the *icaADBC* operon in an *arl* mutant restores catheter colonization. **(A)** Dot blot analysis of the PNAG exopolysaccharide synthesized by the wild type MW2, *arl*, Δ*ica* and the wild type and *arl* mutant that overproduce PNAG through the chromosomal expression of the *icaADBC* operon under the Pcad promoter (P~cd~\_ica and *arl* P~cd~\_ica, respectively). Samples were analyzed after 16 h of static incubation, at 37°C, in TSB media. Samples were spotted onto nitrocellulose membranes and PNAG production was detected with specific anti PIA/PNAG antibodies. Numbers below the image show relative dot quantification according to densitometry analysis performed with ImageJ (<http://rsbweb.nih.gov/ij/>). UD; undiluted sample. **(B)** Comparison of catheter colonization capacity of the strains shown in **(A)**. Bacteria were not detectable in control catheters that had been inoculated with PBS (detection limit 100 CFU/catheter). Note that although a total of ten catheters were inoculated with each strain, a variable number of catheters were recovered in each group due to natural catheter expulsion from mice during the course of the experiment. The plots display values obtained from individual catheters and the mean is represented by horizontal bars. Statistical significance was determined with one-way ANOVA followed by Tukey's multiple comparison test comparing to the WT strain. ^∗∗∗^*P* \< 0.001.](fmicb-09-00342-g004){#F4}

ArlRS Regulates *icaADBC* Expression at the Transcriptional Level
-----------------------------------------------------------------

It has previously been shown that ArlRS regulates *S. epidermidis* biofilm formation by activating *icaADBC* operon expression, probably through repression of IcaR ([@B54]). To analyse if this is the case in *S. aureus*, a sequence upstream of the *ica* operon, including the promoter region of *icaADBC* and the IcaR binding site at the 5′UTR of *ica* genes (-147 to +30), was amplified and cloned into the pCN52 vector ([@B5]), which contains a promoterless *gfpmut2* gene, generating plasmid P~ica(BS)~-gfp. This plasmid was then introduced into *S. aureus* 132 and ISP479r wild type strains and their corresponding *arl* mutants, and expression of the Gfp reporter protein was determined by western-blot. Note that for this analysis, we chose to use such strains instead of *S. aureus* MW2 since as it is shown in **Figure [3](#F3){ref-type="fig"}**, levels of PNAG production in strains 132 and ISP479r are significantly higher than in strain MW2. Results showed that *arl* mutants expressed much lower levels of Gfp compared to wild type strains (**Figure [5A](#F5){ref-type="fig"}**), indicating that ArlRS activates the expression of the *icaADBC* promoter. Next, we examined, by Northern Blot, whether regulation of *ica* promoter expression by ArlRS leads to altered *icaADBC* mRNA levels, using two different riboprobes specific for *icaA* or *icaC* mRNA. Results showed a strong reduction in the levels of *icaA* and *icaC* mRNA in the *arl* mutant compared with the wild type strain (**Figure [5B](#F5){ref-type="fig"}**). Also, we investigated whether the decrease in the amount of *icaADBC* mRNA in the *arl* mutant correlated with lower levels of Ica proteins. To do so, we tagged the chromosomal copy of the *icaC* gene with the 3XFlag sequence in the wild type 132 and ISP479r strains, *arl* mutants and *arl* mutants complemented with a plasmid expressing the *arlRS* genes (*arl* p*arlRS*), and then, we analyzed IcaC production by Western Blot. As expected, IcaC production was abolished in *arl* mutant strains and restored to wild type levels in *arl* p*arlRS* strains (**Figure [5C](#F5){ref-type="fig"}**). Finally, considering that in *S. epidermidis*, [@B54] observed an increase in *icaR* expression in an *arlRS* mutant, we wondered whether in *S. aureus*, the ArlRS TCS activates *icaADBC* operon expression through repression of IcaR. Thus, we determined the levels of *icaR m*RNA in the wild type 132 strain and compared them to the levels occurring in the *arl* mutant and the *arl* mutant complemented with a plasmid expressing the *arlRS* genes. As it is shown in **Figure [5D](#F5){ref-type="fig"}**, mutation of *arl* led to a significant increase in *icaR* mRNA levels that were lowered to approximately wild type levels when the *arl* mutant was complemented with the *arlRS* genes. Collectively, these findings indicated that in *S. aureus*, ArlRS regulates *icaADBC* expression at the transcriptional level, at least through downregulation of *icaR* expression, resulting in the activation of PNAG production.

![ArlRS transcriptionally activates *icaADBC* operon expression in *S. aureus*. **(A)** A representative Western blot showing GFP protein levels expressed from *S. aureus* 132 and ISP479r wild type strains and their corresponding *arl* mutants harboring plasmid P~ica(BS)~-gfp. The GFP protein was detected with commercial anti-GFP antibodies. A stain-free gel portion is shown as a loading control. Numbers below the image show relative band quantification according to densitometry analysis performed with ImageJ (<http://rsbweb.nih.gov/ij/>). **(B)** Representative Northern blots showing *icaA* and *icaC* mRNA of *S. aureus* 132 wild type and *arl* mutant strains grown at 37°C until exponential phase (OD~600\ nm~ = 0.8). Lower panels show 16S ribosome band stained with RedSafe Nucleic Acid Staining Solution as loading control. **(C)** A representative Western blot showing IcaC protein levels of the wild type 132 and ISP479r strains, *arl* mutants and *arl* mutants complemented with a plasmid expressing the *arlRS* genes (*arl* p*arlRS*). The 3XFlag tagged IcaC protein was detected with commercial anti-3XFlag antibodies. A stain-free gel portion is shown as a loading control. Numbers below the image show relative band quantification according to densitometry analysis performed with ImageJ (<http://rsbweb.nih.gov/ij/>). **(D)** A representative Northern blot showing *icaR* mRNA of *S. aureus* 132 wild type strain, *arl* mutant and *arl* mutant complemented with a plasmid expressing the *arlRS* genes (*arl* p*arlRS*) grown at 37°C until exponential phase (OD~600\ nm~ = 0.8). Lower panels show 16S ribosome band stained with RedSafe Nucleic Acid Staining Solution as loading control.](fmicb-09-00342-g005){#F5}

Role of MgrA in the Colonization of Subcutaneous Catheters
----------------------------------------------------------

It is known that ArlRS and the global regulator MgrA form a regulatory cascade (Supplementary Figure [S3A](#SM5){ref-type="supplementary-material"}) in which MgrA acts downstream of ArlRS to control expression of a number of genes important for virulence, including those for several large surface proteins ([@B10]). Also, MgrA seems to regulate PNAG synthesis, since a mutant in *mgrA* has been shown to produce lower levels of PNAG than its corresponding wild type strain ([@B46]). Taken these results into account, we decided to investigate the contribution of MgrA to catheter colonization mediated by the ArlRS TCS. To do so, we firstly constructed a *mgrA* mutant in the MW2 strain and analyzed its capacity to synthesize PNAG by dot blot, using anti PNAG antibodies. The *mgrA* mutant lacked all capacity to produce PNAG (**Figure [6A](#F6){ref-type="fig"}**). We then compared catheter colonization of the *arl* mutant with that of the *mgrA* mutant and verified that both strains showed a similar deficiency in implant colonization. Importantly, catheter colonization capacity of the *mgrA* mutant was restored when the *icaADBC* operon was expressed from the chromosome, under the Pcad promoter (*mgrA*-P~cd~\_ica strain) (**Figure [6B](#F6){ref-type="fig"}**), confirming the requirement of PNAG production for implant colonization. Then, we performed epistatic experiments by overexpressing MgrA in the *arlRS* mutant (Supplementary Figure [S3B](#SM5){ref-type="supplementary-material"}) and analyzing PNAG production and colonization capacity of the resulting strain (*arl* P~cd~\_mgrA). Results showed that MgrA overexpression in the *arlRS* background restored neither PNAG production nor implant colonization capacity, indicating that MgrA activity cannot counteract ArlRS absence.

![MgrA is unable to restore catheter colonization of an *arl* mutant. **(A)** Dot blot analysis of the PNAG exopolysaccharide synthesized by the wild type MW2, *arl*, *mgrA*, *arl* that overproduces MgrA through the chromosomal expression of the *mgrA* gene under the Pcad promoter (*arl* P~cd~\_mgrA), and *mgrA* that overproduces PNAG through the chromosomal expression of the *icaADBC* operon under the Pcad promoter (*mgrA* P~cd~\_ica). Samples were analyzed after 16 h of static incubation, at 37°C, in TSB media. Samples were spotted onto nitrocellulose membranes and PNAG production was detected with specific anti PIA/PNAG antibodies. Numbers below the image show relative dot quantification according to densitometry analysis performed with ImageJ (<http://rsbweb.nih.gov/ij/>). UD; undiluted sample. **(B)** Comparison of catheter colonization capacity of *S. aureus* strains shown in **(A)**. Bacteria were not detectable in control catheters that had been inoculated with PBS (detection limit 100 CFU/catheter). Note that although a total of 10 catheters were inoculated with each strain, a variable number of catheters were recovered in each group due to natural catheter expulsion from mice during the course of the experiment. The plots display values obtained from individual catheters and the mean is represented by horizontal bars. Statistical significance was determined with one-way ANOVA followed by Tukey's multiple comparison test comparing to the WT strain. ^∗∗∗^*P* \< 0.001.](fmicb-09-00342-g006){#F6}

Discussion
==========

Many loss-of-function studies have been performed in several pathogenic bacteria to identify the TCSs required for virulence using *in vivo* infection models ([@B25]; [@B36]; [@B6]; [@B44]). However, to our knowledge, this is the first systematic study conducted to determine the role of each TCS in colonization and survival of *S. aureus* on the surface of an implanted medical device. We used a collection of single mutants in each non-essential TCS of *S. aureus* MW2 and a murine subcutaneous catheter infection model to identify TCSs controlling colonization of the implanted device. It is important to note that none of the single mutants in each TCS show a defect in growth rate when compared to the wild type strain, at least under the laboratory growth conditions tested (Supplementary Figure [S1](#SM3){ref-type="supplementary-material"}). The strongest phenotype in our screening was observed when the *arlRS* TCS was mutated, leading to a greater than 10-fold reduction in the colonization of the catheter. This result was somehow unexpected since other studies have shown that *arlRS* mutants display an increased ability to form a biofilm *in vitro*, due to the release of eDNA ([@B16]; [@B52]) and to the overexpression of SasG, a large surface protein implicated in biofilm formation ([@B10]). Furthermore, [@B45] also showed that mutation of *arlRS* in *S. aureus* 15981 strain, which is naturally defective in *agr*, promoted biofilm formation in a chemically defined media (HHWm) through overexpression of the protein A surface protein. In contrast, mutation of *arlRS* in the closely related *S. epidermidis* reduces biofilm formation capacity both *in vitro* and *in viv*o ([@B54], [@B53]). The molecular mechanism by which ArlRS regulates biofilm formation in *S. epidermidis* has been related with the capacity of ArlR to bind to the promoter region between *icaR* and *icaADBC* and to repress *icaR* expression, which indirectly results in an activation of *icaADBC* expression. In agreement with these results, we showed that ArlRS is involved in the regulation of *icaADBC* expression in *S. aureus*. Deletion of *arlRS* in three genetically unrelated *S. aureus* strains led to a deficiency in PNAG production in TSB media. Transcriptional fusions performed between the *icaADBC* promoter and the *gfp* reporter gene showed that the GFP levels were reduced significantly (about 30%) (**Figure [5A](#F5){ref-type="fig"}**) in the absence of ArlRS. In addition, *icaC* mRNA levels and consequently, IcaC protein levels, were reduced in the *arl* strain. Thus, we concluded that ArlRS regulates *icaADBC* operon expression at the level of transcription. The control that ArlRS exerts over *icaADBC* transcription might occur directly or through another regulatory protein(s). Similarly to what has been demonstrated in *S. epidermidis*, we observed that IcaR expression is upregulated in the absence of ArlRS, strongly suggesting that in *S. aureus*, regulation of *icaADBC* transcription by ArlR is mediated through upregulation of IcaR. Further studies are necessary to determine the direct interaction of ArlR with the promoter of the *icaR* gene.

It is believed that the properties provided by the biofilm lifestyle depend on the composition of the biofilm matrix, which can vary not only between strains but also within the same bacterial strain depending on the environmental conditions. *S. aureus* can form biofilms either made of the PNAG exopolysaccharide or composed by surface proteins such as fibronectin binding proteins, FnBPs, protein A, SasG or Bap ([@B11]; [@B9]; [@B30]; [@B50]). Despite the mutation of *arlRS* leads to an increased expression of several surface proteins, including some involved in multicellular behavior, such as SasG, Ebh, and Spa ([@B16]; [@B52]; [@B10]), in the present study we have shown that none of these proteins seem to play a role in the colonization of implanted catheters. On the contrary, *S. aureus* MW2 required PNAG to form a biofilm on the surface of the subcutaneous catheter. This result was again unexpected since *S. aureus* MW2 is a weak PNAG exopolysaccharide producer under laboratory conditions ([@B46]). This fact warns against the value of *in vitro* PNAG production analysis in order to infer PNAG relevance during infection.

In the present study, we used commercial polyurethane (PU) intravenous catheters. PU is one of the most commonly used material for catheter building due to its high excellent physical properties and good biocompatibility. Analysis of the molecular forces involved in PNAG-mediated adhesion using single-cell force spectroscopy revealed that cationic PNAG binds to anionic surfaces via multivalent electrostatic interactions ([@B13]). During cell-to-cell interactions, it has been proposed that PNAG connects the cells together by electrostatic interaction between its positively charged groups and negatively charged molecules of wall teichoic acids on opposing cells ([@B17]; [@B49]). In the case of cell-implant interaction it seems plausible that PNAG also mediates surface adhesion via electrostatic interactions. On the other hand, adhesion to biological surfaces is often mediated by hydrophobic interactions that are usually the strongest of all long-range non-covalent forces ([@B3]; [@B4]). It is known that hydrophobic materials favor bacterial adherence more than hydrophilic ones and consequently modification of the bacterial surface hydrophobicity can also affect the capacity to colonize the catheter surface ([@B35]). We have not addressed whether surface hydrophobicity is modified in the absence of ArlRS and future studies to clarify this possibility are needed. On the other hand, though bacteria can encounter the naked implant surface, we also need to consider that immediately following the implantation of the catheter, a layer of host proteins rapidly adsorbs on its surface, altering the properties of the polymer which may affect bacterial adhesion and biofilm formation. In our experimental model, catheters were infected immediately after implantation without allowing the catheter to be coated with plasma proteins. This model mimics those infection processes that occur during catheter implantation but we cannot exclude that colonization of a catheter surface coated by plasma may involve additional factors.

ArlR activates expression of one of the promoters of the transcriptional regulator MgrA, also called Rat or NorR ([@B15]; [@B21]; [@B10]). This global regulator modulates the expression of 5--10% of the *S. aureus* genome, and a large part of the ArlRS regulon depends on the expression of MgrA ([@B27]; [@B18]; [@B10]). Based on results shown by [@B46] that indicate that although *S. aureus* mutants in *mgrA* have increased *in vitro* biofilm formation capacity, they produce lower levels of the PNAG exopolysaccharide, we hypothesized that MgrA might be related with the *arlRS* mutant deficiency in catheter colonization. Our results confirmed that an *mgrA* mutant has a decreased PNAG production capacity and also showed that in our catheter infection model, the *mgrA* mutant presents a colonization deficit similar to that of the *arlRS* mutant. Importantly, complementation of both *arlRS* and *mgrA* mutants with the *icaADBC* operon restored implant colonization capacity. However, epistatic experiments revealed that overexpression of MgrA in the *arl* mutant restored neither PNAG production nor implant colonization capacity. These results confirmed the impact that the PNAG exopolysaccharide has for catheter colonization and also indicated that as regards PNAG expression, MgrA activity cannot compensate for ArlRS absence. One plausible explanation for this might be that both regulators regulate *icaADBC* expression at a different level. According to [@B54] and to our results, ArlRS regulates *icaADBC* expression at the transcriptional level through the *icaR* repressor. Instead, MgrA seems to regulate *icaADBC* expression at the posttranscriptional level ([@B46]). These last observations may explain why the *ica* genes have never been identified in studies carried out to define the MgrA regulon ([@B27]; [@B10]).

Our results also showed that deletion of Agr and SrrAB TCSs cause a slight reduction in the capacity to colonize subcutaneous catheters. Agr controls biofilm architecture and cell dispersion through the regulation of phenol soluble modulins (PSMs) in a *ica*-independent manner ([@B34]). PSMs can aggregate and form amyloid fibrils that contribute to stability of the biofilm ([@B41], [@B40]). Because the levels of the PNAG exopolysaccharide produced *in vitro* were similar between the wild type and *agr* mutant strains, it is likely that PNAG is not involved in the decreased colonization capacity of the *agr* mutant *in vivo*. On the other hand, SrrAB has been shown to induce biofilm formation under anaerobic conditions through activation of *icaADBC* gene transcription ([@B47]; [@B55]) and release of extracellular DNA ([@B29]). Since implanted catheters are thought to comprise anaerobic microenvironments, it might be possible that the *srrA* mutant has a catheter colonization deficiency because of a defect linked to oxygen sensing.

In summary, we have shown that ArlRS plays a significant role in *S. aureus* implant colonization by affecting the expression of the *icaADBC* operon by directly modifying *icaR* transcription. Although different studies using different genetic strains coincide in showing that ArlRS plays an important role in biofilm mediated infections, it is also noticeable the strong strain and growth media dependency in the observed phenotypes. Thus, additional studies are necessary to determine the precise mechanisms of regulation and the signals to which this TCS responds.
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